DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base
DarioHealth (DRIO) has secured a new agreement with a Blue Cross Blue Shield (BCBS) health plan, expanding its presence in the health plan market. The program, launched in January 2025, integrates Dario's AI-driven health coaching platform, offering comprehensive cardiometabolic digital health solutions for diabetes, hypertension, and weight management.
The agreement is already contributing to the Company's annual recurring revenue (ARR) in Q1 2025, with expectations for further expansion throughout the year. This marks Dario's ninth health plan partnership, spanning both regional and national payers. The collaboration strengthens Dario's position in the cardiometabolic disease market, which is projected to surpass $1.2 trillion by 2033.
DarioHealth (DRIO) ha siglato un nuovo accordo con un piano sanitario Blue Cross Blue Shield (BCBS), ampliando la sua presenza nel mercato dei piani sanitari. Il programma, lanciato a gennaio 2025, integra la piattaforma di coaching sanitario basata su intelligenza artificiale di Dario, offrendo soluzioni digitali complete per la salute cardiometabolica riguardanti diabete, ipertensione e gestione del peso.
L'accordo sta già contribuendo al fatturato ricorrente annuale (ARR) della Società nel primo trimestre del 2025, con aspettative di ulteriore espansione per tutto l'anno. Questo segna la nona partnership di Dario nel settore dei piani sanitari, che coinvolge sia beneficiari regionali che nazionali. La collaborazione rafforza la posizione di Dario nel mercato delle malattie cardiometaboliche, che si prevede supererà i 1,2 trilioni di dollari entro il 2033.
DarioHealth (DRIO) ha conseguido un nuevo acuerdo con un plan de salud Blue Cross Blue Shield (BCBS), ampliando su presencia en el mercado de planes de salud. El programa, lanzado en enero de 2025, integra la plataforma de coaching de salud impulsada por inteligencia artificial de Dario, ofreciendo soluciones digitales completas para la salud cardiometabólica en diabetes, hipertensión y manejo del peso.
El acuerdo ya está contribuyendo a los ingresos recurrentes anuales (ARR) de la Compañía en el primer trimestre de 2025, con expectativas de una mayor expansión a lo largo del año. Esto marca la novena asociación de Dario con un plan de salud, abarcando tanto proveedores regionales como nacionales. La colaboración fortalece la posición de Dario en el mercado de enfermedades cardiometabólicas, que se proyecta que superará los 1,2 billones de dólares para 2033.
DarioHealth (DRIO)는 Blue Cross Blue Shield (BCBS) 건강 계획과 새로운 계약을 체결하여 건강 계획 시장에서의 입지를 확대했습니다. 2025년 1월에 시작된 이 프로그램은 Dario의 AI 기반 건강 코칭 플랫폼을 통합하여 당뇨병, 고혈압 및 체중 관리를 위한 포괄적인 심혈관 대사 디지털 건강 솔루션을 제공합니다.
이번 계약은 이미 2025년 1분기 회사의 연간 반복 수익(ARR) 증가에 기여하고 있으며, 연말까지 추가 확장을 기대하고 있습니다. 이는 Dario의 아홉 번째 건강 계획 파트너십으로, 지역 및 국가 보험자 모두를 포함하고 있습니다. 이 협력은 2033년까지 1.2조 달러를 초과할 것으로 예상되는 심혈관 대사 질환 시장에서 Dario의 입지를 강화합니다.
DarioHealth (DRIO) a conclu un nouvel accord avec un plan de santé Blue Cross Blue Shield (BCBS), élargissant sa présence sur le marché des plans de santé. Le programme, lancé en janvier 2025, intègre la plateforme de coaching de santé pilotée par IA de Dario, offrant des solutions numériques complètes pour la santé cardiométabolique liées au diabète, à l'hypertension et à la gestion du poids.
L'accord contribue déjà aux revenus annuels récurrents (ARR) de la société au premier trimestre 2025, avec des attentes d'une extension supplémentaire tout au long de l'année. Cela marque le neuvième partenariat de Dario avec un plan de santé, englobant à la fois des payeurs régionaux et nationaux. Cette collaboration renforce la position de Dario sur le marché des maladies cardiométaboliques, qui devrait dépasser 1,2 billion de dollars d'ici 2033.
DarioHealth (DRIO) hat eine neue Vereinbarung mit einem Blue Cross Blue Shield (BCBS) Gesundheitsplan getroffen, um seine Präsenz im Gesundheitsplanmarkt zu erweitern. Das im Januar 2025 gestartete Programm integriert Darios auf KI basierende Gesundheitscoaching-Plattform und bietet umfassende digitale Gesundheitslösungen für die kardiometabolische Gesundheit in Bezug auf Diabetes, Bluthochdruck und Gewichtsmanagement.
Die Vereinbarung trägt bereits zum jährlichen wiederkehrenden Umsatz (ARR) des Unternehmens im ersten Quartal 2025 bei, mit Erwartungen an eine weitere Expansion im Laufe des Jahres. Dies markiert Darios neunte Partnerschaft im Gesundheitsplanbereich, die sowohl regionale als auch nationale Anbieter umfasst. Die Zusammenarbeit stärkt Darios Position im Markt für kardiometabolische Krankheiten, der voraussichtlich bis 2033 über 1,2 Billionen Dollar überschreiten wird.
- New BCBS agreement already contributing to Q1 2025 ARR
- Expansion to ninth health plan partnership
- Expected growth in coverage throughout 2025
- Entry into market projected to reach $1.2T by 2033
- None.
Insights
The new BCBS agreement marks a strategic inflection point for DarioHealth's growth trajectory, particularly significant given their current
First, it provides immediate ARR enhancement starting Q1 2025, with a unique growth characteristic: the contract structure allows for progressive member expansion throughout 2025, creating a built-in growth accelerator. This mirrors successful SaaS models where initial deployment leads to expanded utilization and revenue.
Second, securing a ninth health plan partner demonstrates compelling platform validation, particularly in the AI-driven cardiometabolic space. This is especially noteworthy as healthcare payers are notoriously selective with digital health partnerships, typically requiring extensive validation before commitment.
Third, the timing aligns perfectly with the projected
The company's path to profitability appears increasingly tangible with each major payer addition. These agreements typically feature high margins once scaled, as the technology platform can service additional members with minimal incremental costs. The BCBS partnership particularly strengthens this trajectory by providing both immediate revenue contribution and a clear pathway for expansion across the BCBS network's substantial member base.
DarioHealth expands its payer network with a new Blue Cross Blue Shield agreement, bolstering recurring revenue growth and reinforcing its position in one of healthcare's fastest-growing sectors; Dario's AI-driven digital health platform continues to drive adoption among payers seeking scalable, data-driven solutions
This agreement will integrate the Dario platform's comprehensive cardiometabolic digital health solutions, including programs for diabetes, hypertension, and weight management, into the health plan's suite of member services offered to employers. The agreement is already contributing to the Company's annual recurring revenue (ARR) in Q1 2025, and as with many of the contracts launched in January of 2025, the relationship with this health plan is expected to expand further throughout the year to cover more of the plan's population.
This new collaboration with a BCBS-affiliated plan, a trusted leader in healthcare across the
"We believe that this expansion highlights the increasing demand among payers for scalable, AI-driven digital health solutions that deliver measurable health improvements and cost efficiencies," said Steven Nelson, Chief Commercial Officer at Dario. " We believe that securing another Blue Cross Blue Shield health plan further validates our market leadership in cardiometabolic care and reinforces our ability to scale recurring revenue growth. With nine health plans now leveraging our technology, we are rapidly expanding our presence in the multi-billion-dollar payer market and strengthening our trajectory toward profitability and long-term growth."
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the integration of the Dario platform's digital health solutions into the BCBS health plan, the expectancy that relationship the Company's current health plans will expand further throughout the year to cover more populations, the Company's expanding role in delivering digital cardiometabolic care solutions nationwide, projections with respect to the cardiometabolic disease market, the increasing demand among payers for scalable, AI-driven digital health solutions, and the Company's ability to scale recurring revenue growth, profitability and long-term growth. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the
1https://straitsresearch.com/report/cardiometabolic-disease-market
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo: https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dariohealth-announces-new-blue-cross-blue-shield-agreement-expanding-health-plan-client-base-302370044.html
SOURCE DarioHealth Corp.
FAQ
What is the impact of DRIO's new BCBS agreement on revenue?
How many health plans does DRIO now serve after the BCBS agreement?
What services will DRIO provide under the new BCBS agreement?
When did DRIO's new BCBS program launch?
What is the projected market size for DRIO's cardiometabolic solutions?
